期刊文献+

慢性肾功能衰竭对P-糖蛋白及其介导的药物转运的影响

Influences of chronic renal failure on P-glycoprotein and P-glycoprotein mediated drug transportation
原文传递
导出
摘要 综述慢性肾功能衰竭(chronic renal failure,CRF)对P-糖蛋白(P-glycoproteins,P-gp)及其介导的药物转运的影响。通过查阅资料,选取有代表性的文献,分别从动物水平、细胞水平、临床研究三个方面进行综述。CRF会使药物的肾脏和非肾脏清除发生改变,但不同组织细胞中P-gp的表达与活性改变是不同的,总体而言,CRF会抑制肠道、肾脏和血脑屏障中P-gp的外排作用而促进肝脏中P-gp的药物外排作用。了解CRF对P-gp的影响,充分认识CRF对药物体内过程的影响,将有助于提高CRF患者用药的安全性。 To review the effects of chronic renal failure (CRF) on P-glycoprotein (P-gp) and P-gp mediated drug transporta- tion. Relevant studies were reviewed from animal levels, molecular levels and clinical researches by researching data and selecting representative literatures. CRF could modify renal and non-renal clearance of drugs. However, different tissues and cells had different changes in expression and activity of P-gp. In summary, CRF can inhibit excretion of P-gp in intestine, kidney and blood-brain barrier, but promote excretion of P-gp in liver. It is helpful to improve medication safety in CRF patients by learning the effects of CRF on P-gp, and sufficiently know about the influences of CRP on internal process of drugs in human body.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2015年第5期467-470,共4页 Chinese Journal of Hospital Pharmacy
关键词 慢性肾功能衰竭 P-糖蛋白 药物转运 chronic renal failure P-glycoprotein drug transporting
  • 相关文献

参考文献28

  • 1Momper JD, Venkataramanan R, Nolin TD, et al. Nonrenal Drug Clearance in CKD.. Searching for the Path Less Traveled [J]. Adv Chronic Kidney Dis,2010,17(5):384-391.
  • 2Volpe DA,Tobin GA,Tavakkoli F,et al. Effect of uremic set um and uremic toxins on drug metabolism in human micro- somes[J]. Regul Toxicol Pharmacol, 2014,68 (2) : 297-303.
  • 3Yeung CK, Shen DD, Thummel KE, et al. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport[J]. Kidney Int, 2014,85 (3) : 522.
  • 4Sun H, Frassetto LA, Huang Y, et al. Hepatie clearance, but not gut availability,of Erythromyein is altered in patients with End-Stage Renal Disease [J]. Clin Pharmacol Ther, 2010, 87 (4) : 465-472.
  • 5Amin ML. P-glycoprotein Inhibition for Optimal Drug Delivery [J]. Drug Target Insights,2013,7:27-34.
  • 6刘志浩,刘克辛.肠道药物转运体及其研究方法[J].药学学报,2011,46(4):370-376. 被引量:27
  • 7王丹,饶志,武新安.药物转运体所介导的药物相互作用[J].中国医院药学杂志,2013,33(5):397-399. 被引量:10
  • 8International Transporter Consortium, Giacomini KM, Huang SM,et al. Membrane transporters in drug development[J]. Nat Rev Drug Discov,2010,9(3):215-36.
  • 9黄原原,张浩,易斌,付志敏,阳国平.慢性肾功能不全对药动学影响研究进展[J].中国临床药理学与治疗学,2012,17(6):715-720. 被引量:12
  • 10Laouari D,Yang R,Veau C,et al. Two apical multidrug trans porters, P-gp and MRP2, are differently altered in chronic renal failure [J]. Am J Physiol Renal Physiol, 2001,280 : F636 -F645.

二级参考文献74

  • 1孙进,赵焰平,郝秀华,何仲贵.多药耐药相关蛋白2:在肠道药物处置中的重要作用[J].中国新药与临床杂志,2006,25(10):792-797. 被引量:2
  • 2孙进,陆榕,范晓文,何仲贵.转运蛋白在药物传递中的重要作用[J].中国药学杂志,2007,42(3):164-168. 被引量:1
  • 3Kameyama N, Arisawa S, Ueyama J, et al. Increase in P-glycoprotein accompanied by activation of protein kinase calpha and NF-kappa B p65 in the livers of rats with streptozotocin-induced diabetes [ J ]. Biochim Biophys Acta, 2008,1782 ( 5 ) : 355-360.
  • 4Beaulieu E, Demeule M, Ghitescu L, et al. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain[J]. Biochem JH, 1997,326(2) :539-554.
  • 5Kwan P, Sills GJ, Butler E, et al. Differential expression of multidrug resistance genes in naive rat brain [ J ]. Neurosci Lett, 2003, 339(1 ) :33-36.
  • 6Dan Y, Murakami H, Koyabu N, et al. Distrubution of dompefidone into the rat brain is increased by vrain ischaemia or treatmentwith the P-glycoprotein inhibitor verapamil[ J]. J Pharm Pharmacol, 2002,54(5) :729-733.
  • 7Akria T, Telsuya Y. P-glycoprotein as the drug efllux pump in primary cultured bovine capillary endothelial ceils [ J]. Life sciences, 1992,51 (18) : 1427.
  • 8Bart J, WiUemsen AT, Groen H J, et al. Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of verapamil measured with PET[ J]. Neuroimage, 2003,20 (3) :1775-1782.
  • 9Wang Q, Stran R, Kardos P, et al. Application and limitation of inhibitors in drug-transporter interactions studies [ J ]. Int J Pharm, 2008,356(1-2) :12-18.
  • 10Cistemino S, Rousselle C, DagenJs C, et al. Screening of multidrug-resistance sensitive drugs by in situ brain pergusion in P-glyco- protein-degiclency mice[J]. Harm Res, 2001,18(2) :183-190.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部